NMPA Medical Device and IVD Registration/Filing

NMPA (National Medical Products Administration) has a strict regulatory system for medical device registration and filing. Medical products are classified into Class Ⅰ, Class Ⅱ, and Class Ⅲ in China, with each class corresponding a different registration or filing standard.

NMPA Drug Registration

In China, drugs are classified into traditional Chinese medicine (TCM for short), chemicals and biological products. Please contact us for more details about Chinese regulation requirements and your product registration or filing strategy in China.

NMPA Cosmetic Registration/Filing

Cosmetics are divided into special cosmetics and ordinary cosmetics in China. It has to go through registration or filing before being launched in China. Please contact us for more information about surveillance and registration.

NMPA Medical Device Classification Consulting

The National Medical Products Administration (formerly China Food and Drug Administration, CFDA for short) certifies and approves all medical devices entering into Chinese market. All medical devices, in-vitro diagnostic reagents, and drugs must be filed or registered by the Chinese regulator—the National Medical Products Administration (NMPA).

China Local Legal Agent Service

The local representative is known as the NMPA Legal Agent. The NMPA Legal Agent has an increasingly important role to play as the regulatory emphasis evolves from point-in-time registration focus to whole of lifecycle supervision.

NMPA Cosmetic Ingredient Safety Information Code Application

According to the provisions of new regulations, when declaring cosmetics to NMPA, all ingredients except water must have "raw material quality and safety information documents" before they can be declared, and the applicant must upload the document to the database.

NMPA Product Technical Requirements Support

Product technical requirements are one of the most important documents in medical device registration and are implemented throughout the entire life cycle of medical devices.

NMPA Clinical Trial Application Support

Clinical trial of medical device refers to the process of confirming the safety and effectiveness of medical devices (including in vitro diagnostic reagents) to be applied for registration under normal use conditions in qualified medical device clinical trial institutions.

NMPA Periodic Risks Assessment Report Service

On August 31, 2018, the official website of the National Medical Products Administration issued the "Administrative Measures for Monitoring and Re-evaluation of Medical Device Adverse Events" (State Administration for Market Regulation Order No. 1) (hereinafter referred to as the "Measures"). The Measures put forward a series of new work requirements for medical device registrants, including writing regular risk assessment reports for post-market medical devices.

China Medical Device Advertising Management Service

China's increasingly strict regulation of the pharmaceutical industry has also tightened regulations on the terms and materials used to promote products. We can assist you in checking the content and wording of the company's product advertisements, promotional materials, websites, etc.